Omeros Corporation
General ticker "OMER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $579.5M (TTM average)
Omeros Corporation follows the US Stock Market performance with the rate: 36.7%.
Estimated limits based on current volatility of 3.6%: low 9.57$, high 10.29$
Factors to consider:
- Total employees count: 175 (-13.4%) as of 2025
- Top business risk factors: Commercialization failure, Capital access, Regulatory and compliance, Liquidity and credit risks, Intellectual property risks
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.11$, 17.63$]
- 2026-12-31 to 2027-12-31 estimated range: [4.75$, 14.09$]
Financial Metrics affecting the OMER estimates:
- Positive: with PPE of 7.2 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -37.23 <= 19.19
- Negative: 0.01 < Interest expense per share per price, % of 0.12
Short-term OMER quotes
Long-term OMER plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $164.53MM | $169.26MM | $122.80MM |
| Operating Income | $-164.53MM | $-169.26MM | $-122.80MM |
| Non-Operating Income | $-10.39MM | $-13.37MM | $120.00MM |
| Interest Expense | $30.84MM | $24.68MM | $0.96MM |
| R&D Expense | $114.87MM | $119.52MM | $81.30MM |
| Income(Loss) | $-174.92MM | $-182.63MM | $-2.80MM |
| Taxes | $0.00MM | $0.00MM | $2.01MM |
| Other Income(Loss) | $57.11MM | $25.81MM | $1.46MM |
| Net Income(Loss)* | $-117.81MM | $-156.81MM | $-3.35MM |
| Stockholders Equity | $-24.98MM | $-182.61MM | $-121.23MM |
| Assets | $378.27MM | $277.08MM | $325.63MM |
| Operating Cash Flow | $74.73MM | $-148.80MM | $-116.09MM |
| Capital expenditure | $0.43MM | $0.17MM | $0.07MM |
| Investing Cash Flow | $27.45MM | $82.22MM | $164.52MM |
| Financing Cash Flow | $-106.08MM | $62.88MM | $-42.17MM |
| Earnings Per Share** | $-1.88 | $-2.70 | $-0.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.